Associate Director, Regional Market Access

**Location(s)**: Rome, Italy**

**Level of position**: Associate Director**

**Position type**: office-based**

**Reporting Line**: Senior Director, Price & Market Access, Government Affairs and Communication Europe South**

**How will your role help us transform hope into reality?**

**What will you do?**

Market access strategy in Italy and Iberia
- Develop and coordinate national pricing and reimbursement dossiers
- Be an active player of the negotiation strategy, critically analyze reports from authorities, develop statements for counterarguments, prepare possible oral hearings to support Blueprint Medicines' position
- Lead and coordinate all tasks necessary to the placement of Blueprint Medicines 'solutions in regional and/or hospital formularies, where applicable
- Work closely with other functions, particularly Medical Affairs and Commercial, and interact with external stakeholders
- Collaborate with the International Market Access function to ensure alignment of local and regional market access priorities
- Develop and communicate value tools to internal and external audience, including health economic models that effectively support the decision-making process
- Understand the access decision-making processes for new drugs including horizon scanning, HTA, formularies, and patient pathways
- Tailor financial proposals supporting the use of Blueprint Medicines products to appropriate audiences

Government Affairs and Communications
- Support the development of Government Affairs plan and identify local and national public stakeholders
- Monitor policies that could impact the growth and competitiveness of Blueprint Medicines
- Lead projects that increase the company's visibility in the healthcare context

**What minimum qualifications do we require?**
- A MSc or PhD degree in economics, pharmacy, biology or any other relevant topic.
- Proven and robust experience (6-8 years) from market access work in the industry
- Thorough understanding of the market access dynamics in the countries of responsibility
- Impeccable written and oral communication skills, including strong formal presentation skills.
- A successful track record of product launches, preferably in the Oncology, Hematology or Orphan drug arena.
- Impressive experience and success in developing and executing market access and reimbursement strategies
- A style that fits within Blueprint Medicines' culture and core values, with the highest integrity and ethical behavior, mutual respect for our people
- Entrepreneurial spirit and action, ownership and executions of the tasks and strategic prioritization are non-negotiable competencies
- Pragmatism and ability to synthesize the complexity of the healthcare systems Self
- Feel comfortable working in a high-growth, fast-paced matrix environment that requires impressive flexibility and resilience
- Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

**Why Blueprint?**

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?
- Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors._
- **_Blueflex_**_ is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in-person work with the benefits of added flexibility. Blueflex allows for mix of in-office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources. It is a culture enhancer._

LI-Hybrid

LI-NJ1